1. Home
  2. UEC vs ACLX Comparison

UEC vs ACLX Comparison

Compare UEC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Energy Corp.

UEC

Uranium Energy Corp.

HOLD

Current Price

$14.83

Market Cap

6.6B

ML Signal

HOLD

Logo Arcellx Inc.

ACLX

Arcellx Inc.

HOLD

Current Price

$115.08

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEC
ACLX
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.7B
IPO Year
2008
2022

Fundamental Metrics

Financial Performance
Metric
UEC
ACLX
Price
$14.83
$115.08
Analyst Decision
Strong Buy
Hold
Analyst Count
5
15
Target Price
$18.95
$118.17
AVG Volume (30 Days)
7.5M
1.4M
Earning Date
06-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,837,000.00
$22,286,000.00
Revenue This Year
N/A
$342.39
Revenue Next Year
$220.11
$170.71
P/E Ratio
N/A
N/A
Revenue Growth
29737.95
N/A
52 Week Low
$5.03
$47.86
52 Week High
$20.34
$115.14

Technical Indicators

Market Signals
Indicator
UEC
ACLX
Relative Strength Index (RSI) 53.56 79.86
Support Level $11.86 $63.46
Resistance Level $16.41 N/A
Average True Range (ATR) 0.98 0.11
MACD 0.03 -0.62
Stochastic Oscillator 58.81 84.28

Price Performance

Historical Comparison
UEC
ACLX

About UEC Uranium Energy Corp.

Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Share on Social Networks: